Items where authors include "Barr, A"

Article

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Pastorello, G, Trotta, C, Canfora, E et al. (284 more authors) (2020) The FLUXNET2015 dataset and the ONEFlux processing pipeline for eddy covariance data. Scientific Data, 7 (1). 225. ISSN 2052-4463

Dube, B, Bowes, MA, Hensor, EMA et al. (3 more authors) (2018) The relationship between two different measures of osteoarthritis bone pathology, bone marrow lesions and 3D bone shape: data from the Osteoarthritis Initiative. Osteoarthritis and Cartilage, 26 (10). pp. 1333-1337. ISSN 1063-4584

Tran, G, Cowling, P, Smith, T et al. (5 more authors) (2018) What imaging detected pathologies are associated with shoulder symptoms and their persistence? A systematic literature review. Arthritis Care and Research, 70 (8). pp. 1169-1184. ISSN 2151-464X

Al Arashi, W, Iñiguez Ubiaga, C, Hensor, EM orcid.org/0000-0002-5245-4755 et al. (6 more authors) (2018) Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort. Rheumatology Advances in Practice, 2 (2).

Humby, F, Mahto, A, Ahmed, M et al. (5 more authors) (2017) The Relationship Between Synovial Pathobiology and Magnetic Resonance Imaging Abnormalities in Rheumatoid Arthritis: A Systematic Review. Journal of Rheumatology, 44 (9). pp. 1311-1324. ISSN 0315-162X

Conference or Workshop Item

Dubash, S orcid.org/0000-0002-9303-7122, Bryer, D, Fitton, J et al. (4 more authors) (2018) Personalising care: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is a cost effective strategy in spondyloarthritis. In: Annual European Congress of Rheumatology (EULAR 2018), 13-16 Jun 2018, Amsterdam, Netherlands.

Dubash, S orcid.org/0000-0002-9303-7122, Bryer, D, Fitton, J et al. (4 more authors) (2018) Personalising care: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is a cost effective strategy in spondyloarthritis. In: Eleventh International Congress on Spondyloarthritides, 04-06 Oct 2018, Gent, Belgium.